Literature DB >> 11705949

Immune response genes modulate serologic responses to Vibrio cholerae TcpA pilin peptides.

M D Meeks1, T K Wade, R K Taylor, W F Wade.   

Abstract

Cholera is an enteric disease caused by Vibrio cholerae. Toxin-coregulated pilus (TCP), a type 4 pilus expressed by V. cholerae, is a cholera virulence factor that is required for host colonization. The TCP polymer is composed of subunits of TcpA pilin. Antibodies directed against TcpA are protective in animal models of cholera. While natural or recombinant forms of TcpA are difficult to purify to homogeneity, it is anticipated that synthesized TcpA peptides might serve as immunogens in a subunit vaccine. We wanted to assess the potential for effects of the immune response (Ir) gene that could complicate a peptide-based vaccine. Using a panel of mice congenic at the H-2 locus we tested the immunogenicity of TcpA peptide sequences (peptides 4 to 6) found in the carboxyl termini of both the classical (Cl) and El Tor (ET) biotypes of TCP. Cl peptides have been shown to be immunogenic in CD-1 mice. Our data clearly establish that there are effects of the Ir gene associated with both biotypes of TcpA. These effects are dynamic and dependent on the biotype of TcpA and the haplotypes of the host. In addition to the effects of the classic class II Ir gene, class I (D, L) or nonclassical class I (Qa-2) may also affect immune responses to TcpA peptides. To overcome the effects of the class II Ir gene, multiple TcpA peptides similar to peptides 4, 5, and 6 could be used in a subunit vaccine formulation. Identification of the most protective B-cell epitopes of TcpA within a particular peptide and conjugation to a universal carrier may be the most effective method to eliminate the effects of the class II and class I Ir genes.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11705949      PMCID: PMC98863          DOI: 10.1128/IAI.69.12.7687-7694.2001

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  25 in total

1.  Anti-class II monoclonal antibody-targeted Vibrio cholerae TcpA pilin: modulation of serologic response, epitope specificity, and isotype.

Authors:  J Y Wu; R K Taylor; W F Wade
Journal:  Infect Immun       Date:  2001-12       Impact factor: 3.441

Review 2.  The magnitude of the global problem of diarrhoeal disease: a ten-year update.

Authors:  C Bern; J Martines; I de Zoysa; R I Glass
Journal:  Bull World Health Organ       Date:  1992       Impact factor: 9.408

3.  Control of primary and secondary antibody responses by cytotoxic T lymphocytes specific for a soluble antigen.

Authors:  E Yefenof; R Zehavi-Feferman; R Guy
Journal:  Eur J Immunol       Date:  1990-08       Impact factor: 5.532

4.  Localization of protective epitopes within the pilin subunit of the Vibrio cholerae toxin-coregulated pilus.

Authors:  D X Sun; J M Seyer; I Kovari; R A Sumrada; R K Taylor
Journal:  Infect Immun       Date:  1991-01       Impact factor: 3.441

5.  Immunogenicity of Vibrio cholerae O1 toxin-coregulated pili in experimental and clinical cholera.

Authors:  R H Hall; G Losonsky; A P Silveira; R K Taylor; J J Mekalanos; N D Witham; M M Levine
Journal:  Infect Immun       Date:  1991-07       Impact factor: 3.441

6.  A disease-related epitope of Torpedo acetylcholine receptor. Residues involved in I-Ab binding, self-nonself discrimination, and TCR antagonism.

Authors:  K A Wall; J Y Hu; P Currier; S Southwood; A Sette; A J Infante
Journal:  J Immunol       Date:  1994-05-01       Impact factor: 5.422

7.  TcpA pilin sequences and colonization requirements for O1 and O139 vibrio cholerae.

Authors:  J A Rhine; R K Taylor
Journal:  Mol Microbiol       Date:  1994-09       Impact factor: 3.501

8.  Antibodies directed against the toxin-coregulated pilus isolated from Vibrio cholerae provide protection in the infant mouse experimental cholera model.

Authors:  D X Sun; J J Mekalanos; R K Taylor
Journal:  J Infect Dis       Date:  1990-06       Impact factor: 5.226

9.  Toxin, toxin-coregulated pili, and the toxR regulon are essential for Vibrio cholerae pathogenesis in humans.

Authors:  D A Herrington; R H Hall; G Losonsky; J J Mekalanos; R K Taylor; M M Levine
Journal:  J Exp Med       Date:  1988-10-01       Impact factor: 14.307

10.  Genetic control of the antibody response. I. Demonstration of determinant-specific differences in response to synthetic polypeptide antigens in two strains of inbred mice.

Authors:  H O McDevitt; M Sela
Journal:  J Exp Med       Date:  1965-09-01       Impact factor: 14.307

View more
  5 in total

1.  TcpF is a soluble colonization factor and protective antigen secreted by El Tor and classical O1 and O139 Vibrio cholerae serogroups.

Authors:  Thomas J Kirn; Ronald K Taylor
Journal:  Infect Immun       Date:  2005-08       Impact factor: 3.441

Review 2.  Vibrio cholerae: lessons for mucosal vaccine design.

Authors:  Anne L Bishop; Andrew Camilli
Journal:  Expert Rev Vaccines       Date:  2011-01       Impact factor: 5.217

3.  A Vibrio cholerae classical TcpA amino acid sequence induces protective antibody that binds an area hypothesized to be important for toxin-coregulated pilus structure.

Authors:  Ronald K Taylor; Thomas J Kirn; Michael D Meeks; Terri K Wade; William F Wade
Journal:  Infect Immun       Date:  2004-10       Impact factor: 3.441

4.  Evolution of the Immune Response against Recombinant Proteins (TcpA, TcpB, and FlaA) as a Candidate Subunit Cholera Vaccine.

Authors:  Neda Molaee; Ghasem Mosayebi; Alireza Amozande-Nobaveh; Mohammad Reza Soleyman; Hamid Abtahi
Journal:  J Immunol Res       Date:  2017-01-16       Impact factor: 4.818

5.  Production of putative enhanced oral cholera vaccine strains that express toxin-coregulated pilus.

Authors:  Caitlyn A Hauke; Ronald K Taylor
Journal:  PLoS One       Date:  2017-04-06       Impact factor: 3.240

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.